The Global Leprosy Programme has released the Guidelines for the diagnosis, treatment and prevention of leprosy. The Guidelines provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in low and middle-income countries. The target audience of this document includes policy-makers in leprosy or infectious diseases in the ministries of health (especially but not limited to endemic countries), nongovernmental organizations, clinicians, pharmaceutical companies, donors and affected persons. These leprosy guidelines have been developed by strictly following WHO's GRADE approach wherein all available evidence published in English has been taken into consideration. Funding support for their development was received from The Nippon Foundation.
Dr Laura Gillini from the Global Leprosy Programme (GLP) in collaboration with the WHO Regional Office for Africa and the Country Office of Mozambique visited Mozambique between 14 and 21 February 2018. She was joined by Dr Emmy van der Grinten from the Accelerating Integrated Management (AIM) Initiative. They visited facilities in Maputo, health services in Cabo Delgado province and met dignitaries of Ministries of health and partners of the National leprosy programme led by Dr Francisco Guilengue under the supervision of the Director of Neglected Tropical diseases Dr Marilia Massangaie.
Informal Consultation on stopping discrimination and promoting inclusion of persons affected by leprosy, 14-16 November 2017, New Delhi, India
Leprosy, since ages is associated with deformities in communities where it is prevalent. Ignorance, myths and misconceptions about the disease lead to stigma and to some extent people hesitated to seek treatment for the fear of getting discriminated. Persons affected by leprosy were deprived of social entitlements like disability pensions and contesting elections. Leprosy was ground for divorce in some countries.
Global Leprosy Strategy 2016‒2020; Accelerating towards a leprosy-free World was released in 2016 with a vision of a world without leprosy. The target for stopping discrimination is ‘zero countries with legislations that allow discrimination on the basis of leprosy.
Leprosy in WHO Regions
WHO - Global Leprosy Programme Regional Office for South-East Asia World Health House Indraprastha Estate Mahatma Gandhi Marg New Delhi 110 002, India Phone: +91-11-23370804, 23370809-11 email:email@example.com